PRESCRIPTION RECORD
===================

Patient: John Doe
MRN: MRN-123456
Date: November 20, 2024
Prescribing Physician: Dr. Sarah Mitchell, MD

ACTIVE MEDICATIONS
------------------

1. METFORMIN 1000mg
   - Form: Tablet, Extended Release
   - Dosage: 1000mg twice daily with meals
   - Indication: Type 2 Diabetes Mellitus
   - Start Date: March 2015
   - Refills: 3
   - Instructions: Take one tablet with breakfast and one with dinner
   - Special Notes: May cause GI upset; take with food

2. LISINOPRIL 20mg
   - Form: Tablet
   - Dosage: 20mg once daily
   - Indication: Hypertension
   - Start Date: June 2017
   - Refills: 3
   - Instructions: Take in the morning
   - Special Notes: Monitor blood pressure regularly; avoid potassium supplements

3. ATORVASTATIN 40mg
   - Form: Tablet
   - Dosage: 40mg once daily at bedtime
   - Indication: Hyperlipidemia, Cardiovascular risk reduction
   - Start Date: January 2018
   - Refills: 3
   - Instructions: Take at bedtime
   - Special Notes: Report muscle pain or weakness immediately

4. ASPIRIN 81mg (LOW DOSE)
   - Form: Tablet, Enteric Coated
   - Dosage: 81mg once daily
   - Indication: Cardiovascular prophylaxis
   - Start Date: January 2018
   - Refills: 6
   - Instructions: Take with food
   - Special Notes: Do not discontinue without consulting physician

RECENTLY ADJUSTED MEDICATIONS (New/Changed)
--------------------------------------------

5. EMPAGLIFLOZIN 10mg (NEW - Added today)
   - Form: Tablet
   - Dosage: 10mg once daily
   - Indication: Type 2 Diabetes (adjunct to Metformin), Cardiovascular protection
   - Start Date: November 20, 2024
   - Refills: 3
   - Instructions: Take in the morning with or without food
   - Special Notes: Stay well hydrated; monitor for signs of UTI

DISCONTINUED MEDICATIONS
------------------------
None at this time

MEDICATION COMPLIANCE NOTES
----------------------------
- Patient reports occasionally missing evening Metformin dose
- Blood pressure medication taken regularly
- Statin compliance good but requests bedtime reminder
- New medication (Empagliflozin) prescribed to improve glycemic control

PHARMACIST COUNSELING POINTS
-----------------------------
1. Importance of medication adherence for diabetes management
2. Set phone reminders for evening Metformin dose
3. New medication (Empagliflozin) may cause increased urination
4. Maintain adequate hydration
5. Continue home blood glucose monitoring
6. Report any unusual symptoms immediately

FOLLOW-UP PLAN
--------------
- Schedule appointment in 4 weeks to assess response to new medication
- Bring blood glucose log to next visit
- Continue current dietary modifications
- Lipid panel and HbA1c in 3 months

Next Scheduled Appointment: December 18, 2024

Emergency Contact: (555) 123-4567
Pharmacy: HealthCare Pharmacy, 123 Main St.

Electronically Signed by: Dr. Sarah Mitchell, MD
Date/Time: November 20, 2024 10:45 AM
